Central and peripheral 5-HT uptake in rats treated chronically with femoxetine, paroxetine, and chlorimipramine.
D000818:Animals; D000840:Anisoles / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002997:Clomipramine / Q000494:pharmacology*; D004032:Diet; D004148:Dioxolanes / Q000494:pharmacology; D005260:Female; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D017374:Paroxetine; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000097:blood / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000097:blood; D010133:p-Chloroamphetamine / Q000037:antagonists & inhibitors
D000840:Anisoles; D004148:Dioxolanes; D010880:Piperidines; D012702:Serotonin Antagonists; D012701:Serotonin; D017374:Paroxetine; D010133:p-Chloroamphetamine; C010655:femoxetine; D002997:Clomipramine